Press & event

Vad händer?

Håll dig uppdaterad om våra senaste nyheter och event.

Displaying 1 - 10 of 177

Insights

Conceiving and developing a new drug from scratch can be one of the most satisfying experiences you can have. But it is challenging too – it’s by no means certain that your project will succeed and the more cutting-edge your technology, the higher the risk of failure. 

Insights

Drug development is an exciting field for any business to work in. However, it is not without its challenges, particularly for pharmaceutical start-ups embarking on developing their own newly discovered drug for the first time. 

The likelihood of failure is high for any drug development project, and the risk of this outcome grows the more revolutionary the product. 

Insights

As 2020 is draws to a close, our Chief Executive Officer Thomas Eldered looks back on Recipharm’s key milestones this year in an interview with Nordic Life Science News.

Insights

The plant ‘cannabis sativa’, better known as marijuana, has long been used for medical purposes. Around fifty years ago, researchers started to explore the versatility of marijuana following the discovery of ‘∆9-tetrahydrocannabinol’ (THC), the main psychoactive component of approximately 70 phytocannabinoids. 

Insights

Rafael W. Hartmann, Raphael Fahrner, Dr. Denys Shevshenko, Prof. Mårten Fyrknäs, Prof. Rolf Larsson, Dr. Fredrik Lehmann, Prof. Luke R. Odell

Insights

The auto-injector industry has grown substantially over the last 20 years and is continuing to develop at a rapid rate. This growth is driven by several factors, but particularly the increase in the number of parenteral treatments available for chronic diseases.

Insights

The European Union’s good manufacturing practice (GMP) guide for sterile products, known as Annex 1, has been subject to many changes since the first version was published in 1971.

Insights

Understanding the solution chemistry of the systems evolving from complex multidrug amorphous formulations continues to be a grand challenge in field of drug development of fixed dose combinations (FDCs). In this article, we contribute to advancing the knowledge of FDC formulations by rationalizing the solution behavior of drugs during dissolution and supersaturation.

Insights

Q1. Why is it even important for pharma to be a sustainable industry? Surely healthcare is so important to people, literally vitally so, that pharma gets a free pass when it comes to its environmental impact?

Insights

Analytical chemistry’s role in drug development is to provide assurance of the quality, safety, and efficacy of new medicines. The effectiveness with which these analytical requirements are carried out can also have a marked impact on the speed that a product is ready for market.